Result: Clinical and subclinical symptoms improved markedly after the first PEX: Abdominal pain (decreased from 100% to 50%), bloating (decreased from 100% to 72.3%), increased intra-abdominal pressure (decreased from 63.3% to 16.9%), heart rate (decreased from 108.2 ± 19.2 to 98.1 ± 14.7 times / minute), MAP (increased from 73.4 ± 25.1 to 80.1 ± 30.2 mmHg), triglyceride (decreased by 70.8%), cholesterol (decreased by 61.6%), amylase (decreased by 56.4%), lipase (decreased by 44.4%).